Chemours Co Stock Performance
| CC Stock | USD 14.63 0.03 0.21% |
The firm shows a Beta (market volatility) of 1.54, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chemours will likely underperform. At this point, Chemours has a negative expected return of -0.23%. Please make sure to confirm Chemours' treynor ratio, skewness, and the relationship between the jensen alpha and value at risk , to decide if Chemours performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Chemours Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 0.62 | Five Day Return 3.88 | Year To Date Return (11.91) | Ten Year Return (29.40) | All Time Return (29.40) |
Forward Dividend Yield 0.0684 | Payout Ratio | Forward Dividend Rate 1 | Dividend Date 2025-03-14 | Ex Dividend Date 2025-02-28 |
1 | Insider Trading | 01/03/2025 |
2 | The Chemours Co Announces Upcoming Fourth Quarter 2024 Financial Results Release | 02/03/2025 |
3 | Autel Energy Europe presenta innovadoras soluciones de carga de CA y CC en el Partner Summit Europe 2025 de Pars e informa de un fuerte crecimiento para 2024 | 02/13/2025 |
4 | The Chemours Company Among Last Weeks Worst Dividend Stocks | 02/19/2025 |
5 | Do Options Traders Know Something About Chemours Stock We Dont | 02/28/2025 |
6 | Newmont Completes the Sale of Musselwhite, lonore, and CCV | 03/03/2025 |
7 | Zacks Research Issues Negative Outlook for Chemours Earnings | 03/06/2025 |
8 | Polychlorotrifluoroethylene Market Growth Analysis 2025-2030, Featuring Profiles of Key Players - Daikin Industries, Honeywell International, Arkema, Halopolyme... | 03/07/2025 |
9 | Investing in Chemours five years ago would have delivered you a 89 percent gain | 03/10/2025 |
10 | Chemours Joins University of Kansas-Led Collaborative the Environmentally Applied Refrigerant Technology Hub To Advance Sustainable Cooling Technologies | 03/11/2025 |
11 | Savannah sues 3M, DuPont over alleged PFAS contamination | 03/12/2025 |
12 | Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon 2P50 Product Trial | 03/14/2025 |
| Begin Period Cash Flow | 1.8 B |
Chemours |
Chemours Relative Risk vs. Return Landscape
If you would invest 1,718 in Chemours Co on December 19, 2024 and sell it today you would lose (255.00) from holding Chemours Co or give up 14.84% of portfolio value over 90 days. Chemours Co is generating negative expected returns and assumes 3.0428% volatility on return distribution over the 90 days horizon. Put differently, 27% of stocks are less risky than Chemours on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Chemours Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemours' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chemours Co, and traders can use it to determine the average amount a Chemours' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0745
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CC |
Estimated Market Risk
| 3.04 actual daily | 27 73% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chemours is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chemours by adding Chemours to a well-diversified portfolio.
Chemours Fundamentals Growth
Chemours Stock prices reflect investors' perceptions of the future prospects and financial health of Chemours, and Chemours fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chemours Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0349 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 5.82 B | ||||
| Shares Outstanding | 149.44 M | ||||
| Price To Earning | 25.49 X | ||||
| Price To Book | 3.61 X | ||||
| Price To Sales | 0.38 X | ||||
| Revenue | 5.78 B | ||||
| Gross Profit | 1.15 B | ||||
| EBITDA | 692 M | ||||
| Net Income | 86 M | ||||
| Cash And Equivalents | 1.1 B | ||||
| Cash Per Share | 7.73 X | ||||
| Total Debt | 4.36 B | ||||
| Debt To Equity | 2.94 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (633 M) | ||||
| Earnings Per Share | 0.57 X | ||||
| Market Capitalization | 2.19 B | ||||
| Total Asset | 7.51 B | ||||
| Retained Earnings | 1.72 B | ||||
| Working Capital | 1.22 B | ||||
| Current Asset | 2.3 B | ||||
| Current Liabilities | 1.47 B | ||||
About Chemours Performance
By analyzing Chemours' fundamental ratios, stakeholders can gain valuable insights into Chemours' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chemours has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chemours has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 116.02 | 67.76 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.08 | 0.13 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.14 | 0.18 |
Things to note about Chemours performance evaluation
Checking the ongoing alerts about Chemours for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chemours help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chemours generated a negative expected return over the last 90 days | |
| Chemours has high historical volatility and very poor performance | |
| Chemours Co reports about 1.1 B in cash with (633 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73. | |
| Over 86.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from businesswire.com: Chemours Joins Forces with NTT DATA and Hibiya Engineering, Ltd. For Full-Scale Opteon 2P50 Product Trial |
- Analyzing Chemours' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chemours' stock is overvalued or undervalued compared to its peers.
- Examining Chemours' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chemours' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chemours' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chemours' stock. These opinions can provide insight into Chemours' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |